2022 - Research.com Best Scientist Award
2020 - Member of the National Academy of Medicine (NAM)
2013 - Paul Marks Prize for Cancer Research, Memorial Sloan Kettering Cancer Center
Member of the Association of American Physicians
The scientist’s investigation covers issues in Genetics, Cancer, Cancer research, Gene and Mutation. Exome, Genome, Human genome, Genomics and Germline mutation are the subjects of his Genetics studies. The study incorporates disciplines such as Small hairpin RNA, Computational biology, Human genetics and Bioinformatics in addition to Cancer.
His study in Cancer research is interdisciplinary in nature, drawing from both Cell, Pathology, PI3K/AKT/mTOR pathway, MAPK/ERK pathway and Adenocarcinoma. Oncogene is the focus of his Gene research. His Mutation study deals with Melanoma intersecting with Molecular biology, Antigen, Checkpoint Blockade Immunotherapy, Immune checkpoint and Microphthalmia-associated transcription factor.
Levi A. Garraway mostly deals with Cancer research, Cancer, Genetics, Gene and Melanoma. His Cancer research research integrates issues from Mutation, Colorectal cancer, PI3K/AKT/mTOR pathway and Kinase, MAPK/ERK pathway. His biological study deals with issues like Molecular biology, which deal with fields such as Mutant.
He has included themes like Exome sequencing, Computational biology, Oncology and Bioinformatics in his Cancer study. His Genetics and Genome, Carcinogenesis, Germline mutation, Human genome and Genomics investigations all form part of his Genetics research activities. Levi A. Garraway combines subjects such as Microphthalmia-associated transcription factor, Immunology, Neuroblastoma RAS viral oncogene homolog and Drug resistance with his study of Melanoma.
Cancer research, Cancer, Internal medicine, Exome sequencing and Computational biology are his primary areas of study. Levi A. Garraway studies Melanoma, a branch of Cancer research. His studies in Cancer integrate themes in fields like Precision medicine, DNA methylation, MEDLINE, Bioinformatics and Gene.
Exome sequencing is the subject of his research, which falls under Genetics. The Computational biology study combines topics in areas such as Gene knockdown, Genome, Massive parallel sequencing, Genomics and Human genetics. His Mutation research focuses on subjects like Molecular biology, which are linked to Mutant.
Levi A. Garraway mainly investigates Cancer research, Cancer, Exome sequencing, Computational biology and Immune checkpoint. His studies deal with areas such as Mutation, Ubiquitin ligase, Immune system and Prostate cancer as well as Cancer research. Cancer is a subfield of Genetics that he studies.
When carried out as part of a general Genetics research project, his work on Human cancer and Ubiquitin is frequently linked to work in Dependency, therefore connecting diverse disciplines of study. Levi A. Garraway has researched Exome sequencing in several fields, including DNA Mutational Analysis and Prostate. His work deals with themes such as Microsatellite instability and Gene, Gene knockdown, which intersect with Computational biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina;Giordano Caponigro;Nicolas Stransky;Kavitha Venkatesan.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence;Petar Stojanov;Petar Stojanov;Paz Polak;Paz Polak;Paz Polak;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov.
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei.
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Integrative clinical genomics of advanced prostate cancer
Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz.
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence;Petar Stojanov;Craig H. Mermel;James T. Robinson.
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh;Benjamin Izar;Benjamin Izar;Sanjay M. Prakadan;Marc H. Wadsworth.
A landscape of driver mutations in melanoma
Eran Hodis;Ian R. Watson;Ian R. Watson;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov;Stefan T. Arold.
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan;Nicholas McGranahan;Andrew J. S. Furness;Rachel Rosenthal;Sofie Ramskov.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: